Crixivan and Heart attack - a phase IV clinical study of FDA data
Heart attack is found among people who take Crixivan, especially for people who are male, 40-49 old, have been taking the drug for 1 - 2 years.
The phase IV clinical study analyzes which people take Crixivan and have Heart attack. It is created by eHealthMe based on reports of 6,145 people who have side effects when taking Crixivan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
6,145 people reported to have side effects when taking Crixivan.
Among them, 299 people (4.87%) have Heart attack.
What is Crixivan?
Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,147 Crixivan users for its effectiveness, alternative drugs and more.
What is Heart attack?
Heart attack is found to be associated with 3,628 drugs and 3,114 conditions by eHealthMe.
Number of Crixivan and Heart attack reports submitted per year:
Time on Crixivan when people have Heart attack *:
Gender of people who have Heart attack when taking Crixivan*:
Age of people who have Heart attack when taking Crixivan *:
Common drugs people take besides Crixivan *:
Common side effects people have besides Heart attack *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Crixivan and have Heart attack?Check whether Heart attack is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Heart attack and when was it recovered:
Expand to all the drugs that have ingredients of indinavir sulfate:
Alternative drugs to, pros and cons of Crixivan:
- Crixivan (6,147 reports)
Common Crixivan side effects:
- Fever: 489 reports
- High blood cholesterol: 358 reports
- Lactic acidosis (low ph in body tissues): 324 reports
- Abdominal pain: 312 reports
- Heart attack: 299 reports
- Weakness: 271 reports
Browse all side effects of Crixivan:a b c d e f g h i j k l m n o p q r s t u v w x y z
Heart attack treatments and more:
- Heart attack (252,012 reports)
COVID vaccines that are related to Heart attack:
- Heart attack in Moderna COVID Vaccine
- Heart attack in Pfizer BioNTech Covid Vaccine
- Heart attack in Johnson and Johnson Covid Vaccine
Common drugs associated with Heart attack:
- Avandia: 53,017 reports
- Vioxx: 33,541 reports
- Aspirin: 15,813 reports
- Plavix: 9,606 reports
- Lipitor: 9,141 reports
- Celebrex: 9,103 reports
- Lisinopril: 7,057 reports
- Metformin: 6,826 reports
- Lasix: 5,741 reports
- Prednisone: 5,560 reports
All the drugs that are associated with Heart attack:
- Heart attack (3,628 drugs)
Common conditions associated with Heart attack:
- Diabetes: 46,451 reports
- Rheumatoid arthritis: 8,562 reports
- Arthritis: 7,642 reports
- High blood pressure: 7,474 reports
- Pain: 6,842 reports
All the conditions that are associated with Heart attack:
- Heart attack (3,114 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on indinavir sulfate (the active ingredients of Crixivan) and Crixivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diclofenac Potassium and Otitis Media - 6 seconds ago
- Pregabalin and Urination - Excessive At Night - 12 seconds ago
- Metoprolol Succinate and Ephedrine drug interaction - 12 seconds ago
- Meloxicam and Latent Tuberculosis - 13 seconds ago
- Calcium Carbonate and Conjunctivitis - 18 seconds ago
- Quetiapine Fumarate and Menstrual Disorder - 18 seconds ago
- Lithium Carbonate and Bronchopulmonary Dysplasia - 24 seconds ago
- Linzess and Torsemide drug interaction - 29 seconds ago
- Amlodipine Besylate and Attention Deficit Hyperactivity Disorder - 32 seconds ago
- Amlodipine Besylate and Attention Deficit/Hyperactivity Disorder - 32 seconds ago